Xerient Pharma
Petah Tiqva
About Xerient Pharma
Xerient Pharma is a developer of treatments and diagnostic technologies intended for the treatment of cancer. The company focuses on unmet needs in cancer treatment, particularly in abdominal and gastrointestinal cancers, and pursues the development of novel therapeutic technology that can dramatically improve the survival of these patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $240.0K
- Last round: Series Unknown (Feb 2025)
- Website: xerient.net
Industries & Categories
Biopharma, Biotechnology, Health Care, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/xerient-pharma-176956 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.